
Sign up to save your podcasts
Or


Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.
By ReachMD4.4
1515 ratings
Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

1 Listeners

3 Listeners

3 Listeners

0 Listeners

6 Listeners

18 Listeners

0 Listeners

166 Listeners

56,532 Listeners

1,070 Listeners

385 Listeners